Case Report
Accepted on 29 Sep 2025
Exceptional responses to Trastuzumab Deruxtecan in HER2-positive breast cancer: two illustrative case reports
in Breast Cancer
- 252 views
Case Report
Accepted on 29 Sep 2025
in Breast Cancer
Case Report
Accepted on 29 Sep 2025
in Gastroenterology
Original Research
Accepted on 29 Sep 2025
in Breast Cancer
Case Report
Accepted on 29 Sep 2025
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Accepted on 29 Sep 2025
in Public Health Education and Promotion
Original Research
Accepted on 29 Sep 2025
in Health Economics
Original Research
Accepted on 29 Sep 2025
in Higher Education
Original Research
Accepted on 29 Sep 2025
in Neuropharmacology
Original Research
Accepted on 29 Sep 2025
in Addictive Disorders
Original Research
Accepted on 29 Sep 2025
in Infectious Diseases: Pathogenesis and Therapy
Opinion
Accepted on 29 Sep 2025
in Educational Psychology
Review
Accepted on 29 Sep 2025
in Health Economics
Review
Accepted on 29 Sep 2025
in Healthcare Professions Education
Original Research
Accepted on 29 Sep 2025
in Climate, Ecology and People
Original Research
Accepted on 29 Sep 2025
in Gastrointestinal and Hepatic Pharmacology
Review
Accepted on 29 Sep 2025
in Neurogenesis